Davita Healthcare Partners, Inc. (NYSE:DVA)

CAPS Rating: 4 out of 5

The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.

DVA News and Commentary

Caps

How do you think DVA will perform against the market?

Add Stock to CAPS Watchlist

All Players

403 Outperform
19 Underperform
 

All-Star Players

87 Outperform
7 Underperform
 

Wall Street

15 Outperform
2 Underperform
 

Top DVA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

tidehunter (< 20)
Submitted June 11, 2014

A long-term experiment to see if riding on Buffett's coattails really gets me anywhere.

Madder123458 (< 20)
Submitted January 06, 2016

Although DaVita has large market share and high pricing power, they have used their semi-monopolistic position in the market to demand high premiums and annual "rate inflators" that keep their rates compounding upwards. Because of this heavy-handed… More

DVA VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about DVA.

Recs

1
Member Avatar Madder123458 (< 20) Submitted: 1/5/2016 11:28:36 PM : Underperform Start Price: $68.22 DVA Score: +26.80

Although DaVita has large market share and high pricing power, they have used their semi-monopolistic position in the market to demand high premiums and annual "rate inflators" that keep their rates compounding upwards. Because of this heavy-handed approach, insurance companies have them on their radar as a high cost provider that the recent slew of consolidations will target for savings. And once one of the big insurance companies gets a rate concession from them, there will be chum in the water and the others will be looking for the same.

Also, they had a pretty simple, stable dialysis business model. With their foray into broader healthcare with HCP, they don't have the expertise or infrastructure to run that more complicated business profitably yet. And with pricing pressure on the Medicare side of things, that business will have to adapt quickly to make them a good return on their investment.

Recs

0
Member Avatar jeff1339 (< 20) Submitted: 6/23/2015 5:27:44 PM : Outperform Start Price: $81.55 DVA Score: -36.71

Expectation of continued growth in demand for their services as the population ages. Greatest risk is a potential drug breakthrough, that would make their services obsolete.

Recs

0
Member Avatar reine526 (< 20) Submitted: 5/24/2015 8:25:51 AM : Outperform Start Price: $84.02 DVA Score: -39.13

Company moving to a healthcare model which will deliver primary care to adults with chronic illness such as diabetes and hypertension. This will take them significantly beyond kidney care alone. Although the international division is currently in the red the addition of divisions in China, India, Saudi, and now Latin America is forward thinking.

Leaderboard

Find the members with the highest scoring picks in DVA.

Score Leader

TrackJimCramer

TrackJimCramer (85.36) Score: +173.47

The Score Leader is the player with the highest score across all their picks in DVA.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
abber24 39.05 3/25/2008 Outperform NS $22.10 +257.24% +117.39% +139.85 0 Comment
zoehendricks 35.06 3/24/2008 Outperform NS $22.36 +253.16% +116.16% +137.00 0 Comment
anitaS83 < 20 3/24/2008 Outperform NS $22.37 +253.01% +116.29% +136.72 0 Comment
televester 95.56 3/17/2008 Outperform NS $21.66 +264.58% +132.76% +131.82 0 Comment
marvin1234 < 20 3/24/2008 5/28/2008 Outperform 3M $22.58 +249.65% +119.91% +129.74 1 Comment
LazyTimeMoney 56.93 3/25/2008 Outperform NS $22.83 +245.89% +116.79% +129.10 0 Comment
eatpb < 20 3/14/2008 Outperform 3Y $22.22 +255.39% +128.26% +127.13 0 Comment
Vend01 33.78 3/14/2008 Outperform 1Y $22.67 +248.26% +121.89% +126.37 1 Comment
coach1937 < 20 3/12/2008 Outperform NS $22.89 +244.99% +121.65% +123.33 0 Comment
mezzofool < 20 3/12/2008 Outperform 5Y $23.20 +240.38% +122.93% +117.45 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 85.36 6/4/2015 Underperform 3W $82.60 -4.42% +34.53% +38.95 0 Comment
TrackRWBaird 88.62 4/27/2015 Outperform NS $85.10 -7.23% +33.14% -40.36 0 Comment
TrackGoldmanSach 78.74 7/16/2013 Underperform NS $58.95 +33.93% +68.01% +34.08 0 Comment
TrackDeutscheSec 88.31 4/2/2013 Outperform NS $61.40 +17.30% +24.65% -7.36 8/15/2014 @ $72.02 0 Comment
TrackWayneRogers 54.34 11/16/2012 Outperform 3M $56.51 +39.71% +107.30% -67.59 0 Comment
TrackJPMorgan 88.59 5/3/2012 Outperform NS $42.99 +83.65% +101.43% -17.78 0 Comment
TrackRWBaird 88.62 10/18/2011 Outperform NS $32.50 +32.28% +16.72% +15.55 5/3/2012 @ $42.99 0 Comment
TrackZacks < 20 8/4/2011 Outperform 3M $38.91 +12.84% +13.95% -1.11 3/8/2012 @ $43.90 1 Comment
TrackWMBlair 78.22 7/8/2011 Outperform NS $44.15 +78.81% +111.26% -32.45 0 Comment
TrackCollinsStew 73.10 2/18/2011 Outperform NS $40.03 +97.23% +110.38% -13.15 0 Comment
TrackGoldmanSach 78.74 12/20/2010 Outperform 5Y $35.17 +66.44% +22.31% +44.13 2/15/2013 @ $58.53 1 Comment
TrackFeltlandCo 80.31 9/15/2010 Outperform NS $31.68 +149.25% +151.68% -2.43 0 Comment
TrackStifel 91.95 8/20/2009 Outperform NS $25.92 +204.59% +188.91% +15.68 0 Comment
TrackPiperJaff 85.31 4/27/2009 Outperform NS $22.41 +252.30% +233.12% +19.18 0 Comment
TrackJefferies 76.56 2/11/2009 Outperform NS $23.90 +27.59% +42.81% -15.22 4/28/2010 @ $30.50 0 Comment
TrackRBCCapMkts 87.08 1/29/2009 Outperform NS $24.32 +224.63% +234.02% -9.39 0 Comment
TrackEdwardOwens 99.51 6/13/2008 Outperform 5Y $24.78 +218.67% +117.96% +100.71 2 Comments
TrackSunTrustRH 87.14 6/3/2008 Outperform NS $26.34 +199.79% +110.45% +89.34 0 Comment
TrackCitigroup 93.14 4/29/2008 Outperform NS $25.27 +212.49% +110.41% +102.08 0 Comment
TrackPiperJaff 85.31 3/12/2008 Outperform NS $22.20 +22.41% -6.33% +28.74 7/11/2008 @ $27.17 0 Comment
TrackStanfordRes < 20 1/8/2008 Outperform NS $28.98 +48.13% -2.36% +50.49 4/17/2012 @ $42.92 0 Comment
TrackOppenheimer 58.40 12/18/2007 Outperform NS $28.31 +178.88% +102.72% +76.16 0 Comment
TrackPiperJaff 85.31 11/2/2007 Underperform NS $30.01 -12.51% -12.41% +0.10 1/28/2008 @ $26.25 0 Comment
TrackUBS 92.18 10/8/2007 Outperform NS $32.13 +145.76% +90.75% +55.01 0 Comment
TrackRichAster 99.10 9/30/2007 Outperform NS $31.59 -20.59% -10.95% -9.65 6/16/2008 @ $25.09 1 Comment
TrackJimJubak < 20 9/11/2007 Outperform 1Y $30.08 -3.57% -2.06% -1.51 11/19/2007 @ $29.00 0 Comment
TrackDeutscheSec 88.31 9/4/2007 Outperform NS $29.40 +105.32% +4.92% +100.41 3/7/2013 @ $60.37 0 Comment
TrackPiperJaff 85.31 5/1/2007 Underperform NS $26.90 +4.09% -0.76% -4.85 8/3/2007 @ $28.00 0 Comment
TrackDeutscheSec 88.31 3/13/2007 Outperform NS $26.21 +0.04% +10.61% -10.57 7/18/2007 @ $26.22 0 Comment
TrackPiperJaff 85.31 3/13/2007 Outperform NS $26.25 +2.48% +6.03% -3.55 5/1/2007 @ $26.90 0 Comment
TrackOppenheimer 58.40 12/1/2006 Outperform NS $27.33 +20.73% +8.72% +12.01 10/19/2007 @ $32.99 0 Comment
TrackBofASec 93.94 11/2/2006 Outperform NS $27.65 +185.53% +120.07% +65.47 0 Comment
TrackJimCramer 85.36 9/8/2006 Outperform 3W $28.16 +193.32% +58.81% +134.52 6/4/2015 @ $82.60 0 Comment

Featured Broker Partners